MMP-9 Upregulation is Attenuated by the Monoclonal TLR2 Antagonist T2.5 After Oxygen-Glucose Deprivation and Reoxygenation in Rat Brain Microvascular Endothelial Cells

J Stroke Cerebrovasc Dis. 2019 Jan;28(1):97-106. doi: 10.1016/j.jstrokecerebrovasdis.2018.09.014. Epub 2018 Oct 8.

Abstract

Background: Blood-brain barrier (BBB) disruption plays a key role in the pathophysiology of acute ischemic stroke. Matrix metalloproteinases-2/9 (MMP-2/9) have been shown to participate in the disruption of the BBB and hemorrhagic transformation after cerebral ischemia. Toll-like receptor 2 (TLR2) may also be correlated with endothelial cell injury during ischemia-reperfusion events. However, the correlation between MMP-2/9 and TLR2 on endothelial cells after ischemia has not yet been evaluated. The aim of the study was to evaluate the impact of TLR2 and MMP-2/9 on tight junction proteins (TJs) after oxygen-glucose deprivation and reoxygenation (OGDR).

Materials and methods: Rat primary brain microvascular endothelial cells (BMECs) were cultured. Quantitative real-time PCR and western blotting were used to measure the mRNA and proteins expression of TLR2 and MMP-2/-9. The protein expression of TJs was detected by western blotting and immunofluorescence.

Results: MMP-9 significantly increased after OGDR. Protein and mRNA expression of TLR2 was also upregulated. However, claudin-5, occludin, collagen-Ⅳ, and ZO-1 were decreased after OGDR. When monoclonal anti-TLR2 antibody (T2.5) was added to BMECs after OGDR, MMP-9 was significantly downregulated, whereas occludin and collagen-Ⅳ had a tendency to increase.

Conclusion: TLR2 antagonist T2.5 is able to downregulate the expression of MMP-9, and may constitute a therapeutic option for restoration of the BBB after OGDR.

Keywords: Brain microvascular endothelial cells; anti-TLR2 antibody (T2.5); blood-brain barrier; matrix metalloproteinases-2/9; tight junction proteins; toll like receptor-2.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Brain / blood supply
  • Cardiovascular Agents / pharmacology*
  • Cell Hypoxia / drug effects*
  • Cell Hypoxia / physiology
  • Cells, Cultured
  • Endothelial Cells / drug effects*
  • Endothelial Cells / enzymology
  • Endothelial Cells / pathology
  • Glucose / deficiency*
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism*
  • Microvessels / drug effects
  • Microvessels / enzymology
  • Microvessels / pathology
  • Neuroprotective Agents / pharmacology
  • RNA, Messenger / metabolism
  • Rats, Sprague-Dawley
  • Tight Junction Proteins / metabolism
  • Toll-Like Receptor 2 / antagonists & inhibitors
  • Toll-Like Receptor 2 / metabolism
  • Up-Regulation / drug effects

Substances

  • Antibodies, Monoclonal
  • Cardiovascular Agents
  • Neuroprotective Agents
  • RNA, Messenger
  • Tight Junction Proteins
  • Tlr2 protein, rat
  • Toll-Like Receptor 2
  • monoclonal TLR2 antibody T2.5
  • Matrix Metalloproteinase 2
  • Mmp2 protein, rat
  • Matrix Metalloproteinase 9
  • Mmp9 protein, rat
  • Glucose